Cargando…
A three-year longitudinal evaluation of the forearm bone density of users of etonogestrel- and levonorgestrel-releasing contraceptive implants
BACKGROUND: The aim of this study was to evaluate bone mineral density (BMD) at baseline and at 18 and 36 months of use of etonogestrel (ENG)-and levonorgestrel (LNG)-releasing contraceptive implants. This is a continuation of a previous study in which BMD was evaluated at baseline and at 18 months...
Autores principales: | Monteiro-Dantas, Cecilia, Espejo-Arce, Ximena, Lui-Filho, Jeffrey F, Fernandes, Arlete M, Monteiro, Ilza, Bahamondes, Luis |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2200638/ https://www.ncbi.nlm.nih.gov/pubmed/17997844 http://dx.doi.org/10.1186/1742-4755-4-11 |
Ejemplares similares
-
Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant
por: Ali, Moazzam, et al.
Publicado: (2016) -
Contraceptive sales in the setting of the Zika virus epidemic
por: Bahamondes, Luis, et al.
Publicado: (2017) -
Consecutive Use of the 52 mg Levonorgestrel-releasing Intrauterine System: Variations in Bleeding Patterns
por: Wittmann, Barbara Zantut, et al.
Publicado: (2020) -
Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling
por: Ali, Moazzam, et al.
Publicado: (2017) -
Esters of levonorgestrel and etonogestrel intended as single, subcutaneous-injection, long-lasting contraceptives
por: Meece, Frederick A., et al.
Publicado: (2018)